US Patent 9951077 Aminopyridazinone compounds as protein kinase inhibitors
Patent 9951077 was granted and assigned to Jiangsu Hengrui Medicine on April, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
The present disclosure provides a compound of formula (I) and the use thereof for the therapeutic treatment of human cancers including B-cell lymphoma and autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09951077 Aminopyridazinone compounds as protein kinase inhibitors US Patent 9951077 Aminopyridazinone compounds as protein kinase inhibitors
Infobox
Patent Number
0995107700
Patent Number
995107700
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
099510770
Date of Patent
April 24, 2018
0Patent Application Number
153239290
Date Filed
October 20, 2014
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
099510770
Date of Patent
April 24, 2018
0Patent Application Number
153239290
Date Filed
October 20, 2014
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09951077 Aminopyridazinone compounds as protein kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09951077
Date of patent
April 24, 2018
Patent application number
15323929
Date Filed
October 20, 2014
Patent primary examiner
Find more entities like US Patent 9951077 Aminopyridazinone compounds as protein kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
